Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord

Neurosci Lett. 1992 May 11;139(1):65-8. doi: 10.1016/0304-3940(92)90859-6.

Abstract

The interaction between the spinal antinociceptive effects of selective mu or delta opioid agonists morphine and DSTBULET (Tyr-D-Ser(OtBu)-Gly-Phe-Leu-Thr), respectively, and the selective alpha 2 adrenergic agonist dexmedetomidine was examined on convergent dorsal horn neuronal responses in the intact anaesthetized rat. The coadministration of intrathecal morphine (0.5 microgram, 2.5 micrograms) and dexmedetomidine (0.5 microgram) produced a greater than additive inhibition of C fibre-evoked responses. Inhibitions were reversed by either the opioid antagonist naloxone or the alpha 2 adrenergic antagonist atipamezole. The coadministration of intrathecal DSTBULET (1 microgram, 2.5 micrograms) and dexmedetomidine did not result in a supra-additive inhibition of C fibre-evoked responses. The results suggest that mu rather than delta opioid receptors are involved in the synergism of spinal opioid and alpha 2 adrenergic antinociception.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Adrenergic alpha-Antagonists / pharmacology
  • Amino Acid Sequence
  • Analgesics / pharmacology*
  • Animals
  • Drug Synergism
  • Male
  • Molecular Sequence Data
  • Narcotics / pharmacology*
  • Oligopeptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, delta / drug effects
  • Receptors, Opioid, delta / physiology*
  • Receptors, Opioid, mu / drug effects
  • Receptors, Opioid, mu / physiology*
  • Spinal Cord / drug effects*

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Analgesics
  • Narcotics
  • Oligopeptides
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu
  • tyrosyl-seryl(O-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine